HomeIMNN • NASDAQ
Imunon Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.55M | -1.09% |
Net income | -4.06M | 17.00% |
Net profit margin | — | — |
Earnings per share | -0.25 | — |
EBITDA | -4.11M | 30.31% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.87M | -62.58% |
Total assets | 9.72M | -55.67% |
Total liabilities | 5.47M | -35.84% |
Total equity | 4.24M | — |
Shares outstanding | 14.62M | — |
Price to book | 3.62 | — |
Return on assets | -85.99% | — |
Return on capital | -139.68% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.06M | 17.00% |
Cash from operations | -4.42M | -17.20% |
Cash from investing | -14.91K | 99.55% |
Cash from financing | -3.28K | -110.83% |
Net change in cash | -4.44M | 36.99% |
Free cash flow | -2.86M | -84.10% |
Previous close
$1.05
Day range
$1.01 - $1.04
Year range
$0.64 - $3.65
Market cap
14.91M USD
Avg Volume
132.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1982
Website
Employees
25
